BREAST CANCER / RESEARCH LETTER
 
TOPICS
REFERENCES (15)
1.
Kang B, Lee J, Jung JH, Kim WW, Keum H, Park HY. Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer. Medicine 2023; 102: e34772.
 
2.
Barish R, Gates E, Barac A. Trastuzumab-induced cardiomyopathy. Cardiol Clin 2019; 37: 407-18.
 
3.
Ning B, Liu C, Kucukdagli AC, et al. Proteomic profiling identifies upregulation of aurora kinases causing resistance to taxane-type chemotherapy in triple negative breast cancer. Sci Rep 2025; 15: 3211.
 
4.
Huang X, Song C, Zhang J, Zhu L, Tang H. Circular RNAs in breast cancer diagnosis, treatment and prognosis. Oncol Res 2023; 32: 241-9.
 
5.
Tang Q, Zhou F, Yang C, Dai J, Li J, He Y. CircINTS4 facilitates chemoresistance of TNBC by competitively binding miR-129-5p/POM121 axis. J Oncol 2022; 2022: 2630864.
 
6.
Bao Q, Zhang H, Chen P, et al. The dual roles of circular RNAs in breast cancer distant metastasis and their clinical applications. J Cancer 2025; 16: 3270-82.
 
7.
Tan C, Xie G, Wu S, et al. Simultaneous detection of breast cancer biomarkers circROBO1 and BRCA1 based on a CRISPR-Cas13a/Cas12a system. Biosens Bioelectron 2024; 258: 116373.
 
8.
He F, Guo Q, Jiang GX, Zhou Y. Comprehensive analysis of m6A circRNAs identified in colorectal cancer by MeRIP sequencing. Front Oncol 2022; 12: 927810.
 
9.
Liang G, Ling Y, Lin Q, et al C. MiR-92b-3p inhibits proliferation of HER2-positive breast cancer cell by targeting circCDYL. Front Cell Dev Biol 2021; 9: 707049.
 
10.
Miao S, Zhang Q. Circulating circRNA: a social butterfly in tumors. Front Oncol 2023; 13: 1203696.
 
11.
Zhang S, Xue X, Chen F, et al. COL5A2 drives regorafenib resistance-induced metastatic phenotype via reducing LIFR expression in hepatocellular carcinoma. Acta Biochim Biophys Sin 2024; 56: 997-1010.
 
12.
Liu J, Du Q, Yang Y. Downregulation of circ_0119412 expression inhibits malignant progression of breast cancer by targeting the miR-1205/GALNT6 pathway in vivo and in vitro. Arch Med Sci 2024; 21: 974-90.
 
13.
Xu Y, Gao Z, Sun X, et al. The role of circular RNA during the urological cancer metastasis: exploring regulatory mechanisms and potential therapeutic targets. Cancer Metastasis Rev 2024; 43: 1055-74.
 
14.
Zhang M, Zheng Z, Wang S, et al. The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer. Cancer Drug Resist 2024; 7: 30.
 
15.
Xu A, Zhu L, Yao C, Zhou W, Guan Z. The therapeutic potential of circular RNA in triple-negative breast cancer. Cancer Drug Resist 2024; 7: 13.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top